Treatment of acne
Acne vulgaris is one of the world's most common diseases, and although most patients only experience mild disease there is often demand for therapy. Therapy can be initiated due to objective changes, risk of scarring and self-perceived need of treatment in the patient. The development of isotretinoin has made it possible to control even the most severe degrees of acne. The substance however has a documented potential for teratogenicity which limits its general use. There are however a number of other effective treatments available in clinical practice. Treatment may be topical or systemic, but in most cases the patients will benefit from a combination therapy aimed at different pathogenic steps in the development of acne. Standard treatments and combinations may be suggested based on the primary effects of different drugs.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2000 |
---|---|
Erschienen: |
2000 |
Enthalten in: |
Zur Gesamtaufnahme - volume:162 |
---|---|
Enthalten in: |
Ugeskrift for laeger - 162(2000), 50 vom: 11. Dez., Seite 6840-4 |
Sprache: |
Dänisch |
---|
Weiterer Titel: |
Acnebehandling |
---|
Beteiligte Personen: |
Jemec, G B [VerfasserIn] |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 22.02.2001 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM110992210 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM110992210 | ||
003 | DE-627 | ||
005 | 20231222154652.0 | ||
007 | tu | ||
008 | 231222s2000 xx ||||| 00| ||dan c | ||
028 | 5 | 2 | |a pubmed24n0370.xml |
035 | |a (DE-627)NLM110992210 | ||
035 | |a (NLM)11187138 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dan | ||
100 | 1 | |a Jemec, G B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Treatment of acne |
246 | 3 | 3 | |a Acnebehandling |
264 | 1 | |c 2000 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 22.02.2001 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Acne vulgaris is one of the world's most common diseases, and although most patients only experience mild disease there is often demand for therapy. Therapy can be initiated due to objective changes, risk of scarring and self-perceived need of treatment in the patient. The development of isotretinoin has made it possible to control even the most severe degrees of acne. The substance however has a documented potential for teratogenicity which limits its general use. There are however a number of other effective treatments available in clinical practice. Treatment may be topical or systemic, but in most cases the patients will benefit from a combination therapy aimed at different pathogenic steps in the development of acne. Standard treatments and combinations may be suggested based on the primary effects of different drugs | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Dermatologic Agents |2 NLM | |
650 | 7 | |a Isotretinoin |2 NLM | |
650 | 7 | |a EH28UP18IF |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 162(2000), 50 vom: 11. Dez., Seite 6840-4 |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
773 | 1 | 8 | |g volume:162 |g year:2000 |g number:50 |g day:11 |g month:12 |g pages:6840-4 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 162 |j 2000 |e 50 |b 11 |c 12 |h 6840-4 |